Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001

Emerging Infectious Diseases

Volumn 8, Issue 10, 2002, Pages 1066-1072

  Dewan, Puneet K ^a   Fry, Alicia M ^a   Laserson, Kayla ^a   Tierney, Bruce C ^a   Quinn, Conrad P ^a   Hayslett, James A ^a   Broyles, Laura N ^a   Shane, Andi ^a   Winthrop, Kevin L ^a   Walks, Ivan ^a   Siegel, Larry ^a   Hales, Thomas ^a   Semenova, Vera A ^a   Romero Steiner, Sandra ^a   Elie, Cheryl ^a   Khabbaz, Rima ^a   Khan, Ali S ^a   Hajjeh, Rana A ^a   Schuchat, Anne ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AEROSOL; AIR SAMPLING; ANTHRAX; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SPORE; BACTERIUM CONTAMINATION; BIOLOGICAL WARFARE; CASE REPORT; HEALTH SURVEY; HUMAN; NOSE SMEAR; OCCUPATIONAL EXPOSURE; POSTAL MAIL; SEROPREVALENCE; UNITED STATES; WORKPLACE;

EID: 0036775711     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0810.020330     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wkly Rep 2001;50:909-19.
2. Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, et al. Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States. Emerg Infect Dis 2001;7:933-44.
3. Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. MMWR Morb Mortal Wkly Rep 2001;50:941-8.
4. Centers for Disease Control and Prevention. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. MMWR Morb Mortal Wkly Rep 2001;50:889-93.
5. Plotkin SA, Brachman PS, Utell M, Bumford FH, Atchison MM. An epidemic of inhalation anthrax, the first in the twentieth century: I. Clinical features. 1960. Am J Med 2002;112:4-12.
6. Brachman PS, Plotkin SA, Bumford FH, Atchison MM. An epidemic of inhalation anthrax: The first in the twentieth century. II. Epidemiology. Am J Hyg 1960;72:6-23.
7. Hsu VP, Lukacs SL, Handzel T, Hayslett J, Harper S, Hales T, et al. Opening a Bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: The public health response. Emerg Infect Dis 2002;8;1039-43.
8. Bell DM, Kozarsky PE, Stephens DS. Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax. Emerg Infect Dis 2002;8:222-5.
9. Centers for Disease Control and Prevention. Evaluation of Bacillus anthracis contamination inside the Brentwood Mail Processing and Distribution Center - District of Columbia, October 2001. MMWR Morb Mortal Wkly Rep 2001;50:1129-33.
10. Sanderson W, Stoddard R, Echt A, McCleery RE, Picitelli CA, Kim D, et al. Evaluation of Bacillus Anthracis Contamination Inside the Brentwood Post Office, Washington, D.C. Report to U.S. Postal Service. Cincinnati: National Institute for Occupational Safety and Health; 2001.
11. Sanderson W, Hein M, Taylor L, Curwin B, Kinnes G, Hales T, et al. Second evaluation of Bacillus anthracis contamination inside the Brentwood Mail Processing and Distribution Center, District of Columbia. Report to the U.S. Postal Service. Cincinnati: National Institute for Occupational Safety and Health; 2002.
12. Murray PR. Manual of Clinical Microbiology. 7th Edition. Washington: ASM Press; 1999.
13. Quinn CP, Semenova VA, Elie CM, Romero-Steiner S, Greene C, Li H, et al. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis 2002;8;1103-10.
14. Brachman PS, Pagana JS, Albrink WS. Two cases of fatal inhalation anthrax, one associated with sarcoidosis. N Engl J Med 1961;265:203-8.
15. Dull PM, Wilson KE, Kournikakis B, Whitney EAS, Boulet CA, Ho JYW, et al. Bacillus anthracis aerosolization associated with a contaminated mail sorting machine. Emerg Infect Dis 2002;8;1044-7.
16. Broad WJ, Johnston D. Anthrax sent through mail gained potency by the letter. New York Times 2002 May 7; Sect. A:1.
17. Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A, et al. The Sverdlovsk anthrax outbreak of 1979. Science 1994;266:1202-8.
18. Henderson DW, Peacock S, Belton FC. Observations on the prophylaxis of experimental pulmonary anthrax in the monkey. J Hyg 1956;54:28-36.
19. Iacono-Connors LC, Novak J, Rossi C, Mangiafico J, Ksiazek T. Enzyme-linked immunosorbent assay using a recombinant baculovirus-expressed Bacillus anthracis protective antigen (PA): Measurement of human anti-PA antibodies. Clin Diagn Lab Immunol 1994;1:78-82.
20. Harrison LH, Ezzell JW, Abshire TG, Kidd S, Kaufmann AF. Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay. J Infect Dis 1989;160:706-10.
21. Sirisanthana T, Navachareon N, Tharavichitkul P, Sirisanthana V, Brown AE. Outbreak of oral-oropharyngeal anthrax: An unusual manifestation of human infection with Bacillus anthracis. Am J Trop Med Hyg 1984;33:144-50.
22. Centers for Disease Control and Prevention. CDC interim recommendations for protecting workers from exposure to Bacillus anthracis in work sites where mail is handled or processed. Health Alert Network [online] Oct. 31, 2001 [cited 2002 May 17]; Available from: URL: http://www.cdc.gov/niosh/unp-mailrecs1.html